In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel stenosis and plaque burden vs. an orbital atherectomy system, even after drug-coated balloon ...
VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon Therapy DUBLIN and LAS VEGAS., Medtronic plc announced today the ...
Please provide your email address to receive an email when new articles are posted on . DeRubertis and colleagues enrolled 102 patients (mean age, 70 years; 66% men) with femoropopliteal lesions 8 cm ...
Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and ...
Medtronic ($MDT) announced the U.S. launch of its HawkOne directional atherectomy system, for surgical treatment of peripheral artery disease, or blocked and ...
Medtronic has recalled 95,110 HawkOne Directional Atherectomy Systems because of the risk of the guidewire within the catheter moving downward or prolapsing during use, which may damage the tip of the ...
Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback